Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bja.2024.04.054 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Trends in naloxone co-prescriptions.
Drug Alcohol Depend
December 2024
Stanford University School of Medicine, Office of PA Education, 300 Pasteur Drive, Stanford, CA, United States; Stanford University School of Medicine, Department of Medicine, Division of Primary Care and Population Health, 300 Pasteur Drive, Stanford, CA, United States; Kaiser Permanente Mountain View Medical Offices, Department of Internal Medicine, 555 Castro Street, Mountain View, CA, United States. Electronic address:
Background: The opioid epidemic remains a significant public health crisis in the United States. Naloxone has been identified as a critical component in combating this crisis. However, co-prescription rates among patients receiving opioids remain suboptimal, especially among certain high-risk populations.
View Article and Find Full Text PDFIterative Development of a Clinical Decision Support Tool to Enhance Naloxone Co-Prescribing.
Appl Clin Inform
October 2024
Quality and Safety, Boston Medical Center, Boston, United States.
Background Opioid overdoses have contributed significantly to mortality in the United States. Despite long-standing recommendations from the Centers for Disease Control and Prevention to co-prescribe naloxone for patients receiving opioids who are at high risk of overdose, compliance with these guidelines has remained low. Objectives The objective of this study was to develop and evaluate a hospital-wide electronic health record (EHR)-based clinical decision support (CDS) tool designed to promote naloxone co-prescription for high-risk opioids.
View Article and Find Full Text PDFImpact of California's naloxone co-prescription law on emergency department visits, 30-day mortality, and prescription patterns.
J Am Coll Emerg Physicians Open
October 2024
Objective: Opioid overdose is a public health epidemic adversely impacting individuals and communities. To combat this, California passed a law mandating that prescribers offer a naloxone prescription in certain circumstances. Our objective was to evaluate associations with California's naloxone prescription mandate and emergency department (ED) overdose visits/hospitalizations, opioid and naloxone prescribing, and 30-day mortality.
View Article and Find Full Text PDFPerceptions Toward Naloxone Among Patients With Cancer Receiving Opioids.
J Pain Symptom Manage
December 2024
Department of Palliative, Rehabilitation and Integrative Medicine (J.A.D., M.J.K., S.D., R.D., K.T., S.A., A.Z.M., L.A.T., P.B., D.H., J.A., A.H., E.B., A.K.), The University of Texas MD Anderson Cancer, Houston, Texas, USA.
Context: Naloxone nasal spray is recommended for patients with risk factors for opioid overdose. However, cancer patients' perceptions and beliefs regarding naloxone prescriptions and their self-perceived risks for overdose are understudied.
Objective: To determine the proportion of cancer patients at risk for overdose who perceived naloxone as beneficial.
Improving Naloxone Co-prescribing Through Clinical Decision Support.
Cureus
July 2024
Anesthesia, University of Iowa Hospitals and Clinics, Iowa City, USA.
Background: Despite national guidelines recommending naloxone co-prescription with high-risk medications, rates remain low nationally. This was reflected at our institution with remarkably low naloxone prescribing rates. We sought to determine if a clinical decision support (CDS) tool could increase rates of naloxone co-prescribing with high-risk prescriptions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!